Alanine 0 7 0 7 B-clinical_variable
aminotransferase 8 24 8 24 I-clinical_variable
( 25 26 25 26 I-clinical_variable
ALT 26 29 26 29 I-clinical_variable
) 29 30 29 30 I-clinical_variable
or 31 33 31 33 O
aspartate 34 43 34 43 B-clinical_variable
aminotransferase 44 60 44 60 I-clinical_variable
( 61 62 61 62 I-clinical_variable
AST 62 65 62 65 I-clinical_variable
) 65 66 65 66 I-clinical_variable
must 67 71 67 71 O
be 72 74 72 74 O
less 75 79 75 79 O
than 80 84 80 84 O
3 85 86 85 86 B-upper_bound
times 87 92 87 92 I-upper_bound
the 93 96 93 96 I-upper_bound
upper 97 102 97 102 I-upper_bound
limit 103 108 103 108 I-upper_bound
of 109 111 109 111 I-upper_bound
the 112 115 112 115 I-upper_bound
normal 116 122 116 122 I-upper_bound
range 123 128 123 128 I-upper_bound

Carriers 0 8 129 137 O
of 9 11 138 140 O
hepatitis 12 21 141 150 B-chronic_disease
B 22 23 151 152 I-chronic_disease
virus 24 29 153 158 I-chronic_disease
should 30 36 159 165 O
be 37 39 166 168 O
closely 40 47 169 176 O
monitored 48 57 177 186 O
for 58 61 187 190 O
clinical 62 70 191 199 O
and 71 74 200 203 O
laboratory 75 85 204 214 O
signs 86 91 215 220 O
of 92 94 221 223 O
active 95 101 224 230 O
hepatitis 102 111 231 240 B-chronic_disease
B 112 113 241 242 I-chronic_disease
virus 114 119 243 248 I-chronic_disease
infection 120 129 249 258 I-chronic_disease
and 130 133 259 262 O
for 134 137 263 266 O
signs 138 143 267 272 O
of 144 146 273 275 O
hepatitis 147 156 276 285 O
throughout 157 167 286 296 O
study 168 173 297 302 O
participation 174 187 303 316 O

Composite 0 9 317 326 B-cancer
lymphoma 10 18 327 335 I-cancer
containing 19 29 336 346 O
both 30 34 347 351 O
indolent 35 43 352 360 O
and 44 47 361 364 O
large 48 53 365 370 O
cell 54 58 371 375 O
features 59 67 376 384 O
will 68 72 385 389 O
be 73 75 390 392 O
included 76 84 393 401 O

Eastern 0 7 402 409 B-clinical_variable
Cooperative 8 19 410 421 I-clinical_variable
Oncology 20 28 422 430 I-clinical_variable
Group 29 34 431 436 I-clinical_variable
( 35 36 437 438 I-clinical_variable
ECOG 36 40 438 442 I-clinical_variable
) 40 41 442 443 I-clinical_variable
performance 42 53 444 455 I-clinical_variable
status 54 60 456 462 I-clinical_variable
of 61 63 463 465 O
0 64 65 466 467 B-lower_bound
- 65 66 467 468 O
3 66 67 468 469 B-upper_bound

Has 0 3 470 473 O
received 4 12 474 482 O
no 13 15 483 485 O
prior 16 21 486 491 B-treatment
therapy 22 29 492 499 I-treatment
for 30 33 500 503 O
DLBCL 34 39 504 509 B-cancer
or 40 42 510 512 O
HT 43 45 513 515 B-chronic_disease
with 46 50 516 520 O
the 51 54 521 524 O
exception 55 64 525 534 O
of 65 67 535 537 O
a 68 69 538 539 O
course 70 76 540 546 O
of 77 79 547 549 O
prednisone 80 90 550 560 B-treatment
of 91 93 561 563 O
less 94 98 564 568 O
than 99 103 569 573 O
or 104 106 574 576 O
equal 107 112 577 582 O
to 113 115 583 585 O
7 116 117 586 587 B-upper_bound
days 118 122 588 592 I-upper_bound
given 123 128 593 598 O
for 129 132 599 602 O
lymphoma 133 141 603 611 B-cancer
related 142 149 612 619 O
symptoms 150 158 620 628 O
; 158 159 628 629 O
prior 160 165 630 635 O
therapy 166 173 636 643 O
for 174 177 644 647 O
follicular 178 188 648 658 B-cancer
lymphoma 189 197 659 667 I-cancer
is 198 200 668 670 O
accepted 201 209 671 679 O
, 209 210 679 680 O
but 211 214 681 684 O
no 215 217 685 687 O
prior 218 223 688 693 B-treatment
anthracycline 224 237 694 707 I-treatment
- 237 238 707 708 I-treatment
containing 238 248 708 718 I-treatment
therapy 249 256 719 726 I-treatment

History 0 7 727 734 O
of 8 10 735 737 O
solid 11 16 738 743 B-treatment
organ 17 22 744 749 I-treatment
transplantation 23 38 750 765 I-treatment
, 38 39 765 766 O
or 40 42 767 769 O
post 43 47 770 774 B-chronic_disease
- 47 48 774 775 I-chronic_disease
transplant 48 58 775 785 I-chronic_disease
lymphoproliferative 59 78 786 805 I-chronic_disease
disorder 79 87 806 814 I-chronic_disease

History 0 7 815 822 O
of 8 10 823 825 O
, 10 11 825 826 O
or 12 14 827 829 O
clinically 15 25 830 840 O
apparent 26 34 841 849 O
central 35 42 850 857 B-cancer
nervous 43 50 858 865 I-cancer
system 51 57 866 872 I-cancer
( 58 59 873 874 I-cancer
CNS 59 62 874 877 I-cancer
) 62 63 877 878 I-cancer
lymphoma 64 72 879 887 I-cancer

New 0 3 888 891 B-clinical_variable
York 4 8 892 896 I-clinical_variable
Heart 9 14 897 902 I-clinical_variable
Association 15 26 903 914 I-clinical_variable
class 27 32 915 920 B-chronic_disease
III 33 36 921 924 I-chronic_disease
heart 37 42 925 930 I-chronic_disease
failure 43 50 931 938 I-chronic_disease
or 51 53 939 941 O
ejection 54 62 942 950 B-clinical_variable
fraction 63 71 951 959 I-clinical_variable
of 72 74 960 962 O
less 75 79 963 967 O
than 80 84 968 972 O
30 85 87 973 975 B-upper_bound
% 87 88 975 976 I-upper_bound
on 89 91 977 979 O
echocardiogram 92 106 980 994 B-treatment
or 107 109 995 997 O
Multi 110 115 998 1003 B-treatment
Gated 116 121 1004 1009 I-treatment
Acquisition 122 133 1010 1021 I-treatment
Scan 134 138 1022 1026 I-treatment
( 139 140 1027 1028 I-treatment
MUGA 140 144 1028 1032 I-treatment
) 144 145 1032 1033 I-treatment

Patient 0 7 1034 1041 O
has 8 11 1042 1045 O
a 12 13 1046 1047 O
calculated 14 24 1048 1058 O
or 25 27 1059 1061 O
measured 28 36 1062 1070 O
creatinine 37 47 1071 1081 B-clinical_variable
clearance 48 57 1082 1091 I-clinical_variable
of 58 60 1092 1094 O
< 61 62 1095 1096 O
30 62 64 1096 1098 B-upper_bound
mL 65 67 1099 1101 I-upper_bound
/ 67 68 1101 1102 I-upper_bound
minute 68 74 1102 1108 I-upper_bound
within 75 81 1109 1115 O
14 82 84 1116 1118 B-upper_bound
days 85 89 1119 1123 I-upper_bound
before 90 96 1124 1130 O
enrollment 97 107 1131 1141 O

Patient 0 7 1142 1149 O
has 8 11 1150 1153 O
a 12 13 1154 1155 O
platelet 14 22 1156 1164 B-clinical_variable
count 23 28 1165 1170 I-clinical_variable
of 29 31 1171 1173 O
≤50,000 32 39 1174 1181 O
/ 39 40 1181 1182 I-upper_bound
mm3 40 43 1182 1185 I-upper_bound
within 44 50 1186 1192 O
14 51 53 1193 1195 B-upper_bound
days 54 58 1196 1200 I-upper_bound
before 59 65 1201 1207 O
enrollment 66 76 1208 1218 O

Patient 0 7 1219 1226 O
has 8 11 1227 1230 O
an 12 14 1231 1233 O
absolute 15 23 1234 1242 B-clinical_variable
neutrophil 24 34 1243 1253 I-clinical_variable
count 35 40 1254 1259 I-clinical_variable
of 41 43 1260 1262 O
< 44 45 1263 1264 O
1,000 46 51 1265 1270 B-upper_bound
/ 51 52 1270 1271 I-upper_bound
mm3 52 55 1271 1274 I-upper_bound
within 56 62 1275 1281 O
14 63 65 1282 1284 B-upper_bound
days 66 70 1285 1289 I-upper_bound
before 71 77 1290 1296 O
enrollment 78 88 1297 1307 O

Patient 0 7 1308 1315 O
has 8 11 1316 1319 O
concomitant 12 23 1320 1331 O
active 24 30 1332 1338 B-cancer
malignancy 31 41 1339 1349 I-cancer
that 42 46 1350 1354 O
the 47 50 1355 1358 O
treating 51 59 1359 1367 O
physician 60 69 1368 1377 O
or 70 72 1378 1380 O
PI 73 75 1381 1383 O
feels 76 81 1384 1389 O
may 82 85 1390 1393 O
interfere 86 95 1394 1403 O
with 96 100 1404 1408 O
the 101 104 1409 1412 O
ability 105 112 1413 1420 O
to 113 115 1421 1423 O
measure 116 123 1424 1431 O
the 124 127 1432 1435 O
primary 128 135 1436 1443 O
or 136 138 1444 1446 O
secondary 139 148 1447 1456 O
outcomes 149 157 1457 1465 O

Patient 0 7 1466 1473 O
has 8 11 1474 1477 O
received 12 20 1478 1486 O
other 21 26 1487 1492 O
investigational 27 42 1493 1508 O
drugs 43 48 1509 1514 O
with 49 53 1515 1519 O
14 54 56 1520 1522 B-upper_bound
days 57 61 1523 1527 I-upper_bound
before 62 68 1528 1534 O
enrollment 69 79 1535 1545 O

Patient 0 7 1546 1553 O
has 8 11 1554 1557 O
≥Grade 12 18 1558 1564 O
2 19 20 1565 1566 I-lower_bound
peripheral 21 31 1567 1577 B-clinical_variable
neuropathy 32 42 1578 1588 I-clinical_variable
within 43 49 1589 1595 O
14 50 52 1596 1598 B-upper_bound
days 53 57 1599 1603 I-upper_bound
before 58 64 1604 1610 O
enrollment 65 75 1611 1621 O

Patient 0 7 1622 1629 O
is 8 10 1630 1632 O
known 11 16 1633 1638 O
to 17 19 1639 1641 O
be 20 22 1642 1644 O
HIV 23 26 1645 1648 B-chronic_disease
positive 27 35 1649 1657 O
( 36 37 1658 1659 O
test 37 41 1659 1663 O
result 42 48 1664 1670 O
not 49 52 1671 1674 O
required 53 61 1675 1683 O
for 62 65 1684 1687 O
enrollment 66 76 1688 1698 O
) 76 77 1698 1699 O

Patient 0 7 1700 1707 O
is 8 10 1708 1710 O
receiving 11 20 1711 1720 O
peritoneal 21 31 1721 1731 B-treatment
dialysis 32 40 1732 1740 I-treatment
or 41 43 1741 1743 O
hemodialysis 44 56 1744 1756 B-treatment

Patients 0 8 1757 1765 O
with 9 13 1766 1770 O
HT 14 16 1771 1773 B-chronic_disease
must 17 21 1774 1778 O
not 22 25 1779 1782 O
have 26 30 1783 1787 O
received 31 39 1788 1796 O
an 40 42 1797 1799 O
anthracycline 43 56 1800 1813 B-treatment
- 56 57 1813 1814 O
containing 57 67 1814 1824 O
regimen 68 75 1825 1832 O
in 76 78 1833 1835 O
the 79 82 1836 1839 O
past 83 87 1840 1844 O

Patients 0 8 1845 1853 O
with 9 13 1854 1858 O
a 14 15 1859 1860 O
history 16 23 1861 1868 O
of 24 26 1869 1871 O
curative 27 35 1872 1880 O
, 35 36 1880 1881 O
surgically 37 47 1882 1892 O
treated 48 55 1893 1900 O
basal 56 61 1901 1906 B-cancer
or 62 64 1907 1909 I-cancer
squamous 65 73 1910 1918 I-cancer
cell 74 78 1919 1923 I-cancer
carcinoma 79 88 1924 1933 I-cancer
or 89 91 1934 1936 O
stage 92 97 1937 1942 B-cancer
1 98 99 1943 1944 I-cancer
melanoma 100 108 1945 1953 I-cancer
of 109 111 1954 1956 I-cancer
the 112 115 1957 1960 I-cancer
skin 116 120 1961 1965 I-cancer
or 121 123 1966 1968 O
in 124 126 1969 1971 B-cancer
situ 127 131 1972 1976 I-cancer
carcinoma 132 141 1977 1986 I-cancer
of 142 144 1987 1989 I-cancer
the 145 148 1990 1993 I-cancer
cervix 149 155 1994 2000 I-cancer
are 156 159 2001 2004 O
eligible 160 168 2005 2013 O

Patients 0 8 2014 2022 O
with 9 13 2023 2027 O
a 14 15 2028 2029 O
malignancy 16 26 2030 2040 B-cancer
that 27 31 2041 2045 O
has 32 35 2046 2049 O
been 36 40 2050 2054 O
treated 41 48 2055 2062 O
with 49 53 2063 2067 O
surgery 54 61 2068 2075 B-treatment
alone 62 67 2076 2081 O
with 68 72 2082 2086 O
curative 73 81 2087 2095 O
intent 82 88 2096 2102 O
will 89 93 2103 2107 O
also 94 98 2108 2112 O
be 99 101 2113 2115 O
excluded 102 110 2116 2124 O
, 110 111 2124 2125 O
unless 112 118 2126 2132 O
the 119 122 2133 2136 O
malignancy 123 133 2137 2147 O
has 134 137 2148 2151 O
been 138 142 2152 2156 O
in 143 145 2157 2159 O
documented 146 156 2160 2170 O
remission 157 166 2171 2180 O
without 167 174 2181 2188 O
treatment 175 184 2189 2198 B-treatment
for 185 188 2199 2202 O
≥ 189 190 2203 2204 O
3 191 192 2205 2206 B-lower_bound
years 193 198 2207 2212 I-lower_bound
prior 199 204 2213 2218 I-lower_bound
to 205 207 2219 2221 O
enrollment 208 218 2222 2232 O

Prior 0 5 2233 2238 O
exposure 6 14 2239 2247 O
to 15 17 2248 2250 O
anthracycline 18 31 2251 2264 B-treatment

Serious 0 7 2265 2272 B-chronic_disease
medical 8 15 2273 2280 I-chronic_disease
or 16 18 2281 2283 I-chronic_disease
psychiatric 19 30 2284 2295 I-chronic_disease
illness 31 38 2296 2303 I-chronic_disease
likely 39 45 2304 2310 O
to 46 48 2311 2313 O
interfere 49 58 2314 2323 O
with 59 63 2324 2328 O
participation 64 77 2329 2342 O
in 78 80 2343 2345 O
this 81 85 2346 2350 O
clinical 86 94 2351 2359 O
study 95 100 2360 2365 O

Total 0 5 2366 2371 O
bilirubin 6 15 2372 2381 B-clinical_variable
must 16 20 2382 2386 O
be 21 23 2387 2389 O
less 24 28 2390 2394 O
than 29 33 2395 2399 O
1.5 34 37 2400 2403 B-upper_bound
times 38 43 2404 2409 I-upper_bound
the 44 47 2410 2413 I-upper_bound
upper 48 53 2414 2419 I-upper_bound
limit 54 59 2420 2425 I-upper_bound
of 60 62 2426 2428 I-upper_bound
normal 63 69 2429 2435 I-upper_bound
( 70 71 2436 2437 I-upper_bound
ULN 71 74 2437 2440 I-upper_bound
) 74 75 2440 2441 I-upper_bound
unless 76 82 2442 2448 O
the 83 86 2449 2452 O
elevation 87 96 2453 2462 O
is 97 99 2463 2465 O
known 100 105 2466 2471 O
to 106 108 2472 2474 O
be 109 111 2475 2477 O
due 112 115 2478 2481 O
to 116 118 2482 2484 O
Gilbert 119 126 2485 2492 B-chronic_disease
syndrome 127 135 2493 2501 I-chronic_disease

aged 0 4 2502 2506 B-age
greater 5 12 2507 2514 O
than 13 17 2515 2519 O
or 18 20 2520 2522 O
equal 21 26 2523 2528 O
to 27 29 2529 2531 O
75 30 32 2532 2534 B-lower_bound
years 33 38 2535 2540 I-lower_bound
of 39 41 2541 2543 O
age 42 45 2544 2547 O

women 0 5 2548 2553 B-gender

